We are live on ! Find out more
IMRX icon

Immuneering
IMRX

37 hedge funds and large institutions have $200M invested in Immuneering in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 4

1.53% more ownership

Funds ownership: 46.67% → 48.19% (+1.5%)

3% less funds holding

Funds holding: 38 → 37 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

37% less capital invested

Capital invested by funds: $316M → $200M (-$116M)

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
20
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.64M
2
BlackRock
BlackRock
New York
+$4.67M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.81M
4
CAM
Cormorant Asset Management
Massachusetts
+$1.22M
5
State Street
State Street
Massachusetts
+$456K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.1M
2
Millennium Management
Millennium Management
New York
-$1.46M
3
CCM
CAAS Capital Management
New York
-$1.06M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$723K
5
GCM
Ghisallo Capital Management
Massachusetts
-$398K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$81K +$6.57K +270 +6%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$75K +$71.5K +2,937 +173%
AIG
28
American International Group
New York
$72K -$1.41K -58 -1%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$72K – – –
Citigroup
30
Citigroup
New York
$48K +$41.7K +1,712 +137%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$32K +$26.5K +1,090 +125%
SO
32
STRS Ohio
Ohio
$30K – – –
UBS Group
33
UBS Group
Switzerland
$26K +$12.2K +501 +45%
TRCT
34
Tower Research Capital (TRC)
New York
$21K +$26.2K +1,077 +462%
Legal & General Group
35
Legal & General Group
United Kingdom
$13K – – –
AIP
36
Ameritas Investment Partners
Nebraska
$10K – – –
Daiwa Securities Group
37
Daiwa Securities Group
Japan
$1K +$1.85K +76 New
CCM
38
CAAS Capital Management
New York
– -$1.06M -40,000 Closed
GCM
39
Ghisallo Capital Management
Massachusetts
– -$398K -15,000 Closed
Marshall Wace
40
Marshall Wace
United Kingdom
– -$349K -13,149 Closed
MIM
41
MetLife Investment Management
New Jersey
– -$98.7K -3,719 Closed
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
– -$74.7K -2,814 Closed
1
2

IMRX Hedge Fund Activity: Q4 2021 in Review

37 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Immuneering (IMRX) for Q4 2021, worth a combined $200M — down 37% from $316M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IMRX and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 20 added.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $7.64M. The largest seller was Fidelity Investments, cutting an estimated $4.1M.

  • 37 institutional investors held Immuneering (IMRX) as of Q4 2021, down from 38 in Q3 2021.
  • Funds reported $200M of Immuneering stock for Q4 2021, down 37% quarter-over-quarter.
  • 4 funds opened new Immuneering positions in Q4 2021 and 5 closed out, a net change of -1 holder.
  • The largest Immuneering buyer in Q4 2021 was Adage Capital Partners, an estimated $7.64M added.
  • The largest Immuneering seller in Q4 2021 was Fidelity Investments, an estimated $4.1M sold.

Based on aggregated 13F filings for Q4 2021.